Financial Snapshot

Revenue
$3.551M
TTM
Gross Margin
Net Earnings
-$599.5M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
674.12%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
$948.7M
Q3 2024
Book Value
$191.1M
Q3 2024
Cash
Q3 2024
P/E
-4.797
Nov 29, 2024 EST
Free Cash Flow
-$604.3M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1993 1992 1991
Revenue $3.551M $240.7M $243.2M $138.3M $87.99M $168.8M $16.14M $31.41M $200.0K $400.0K $175.0K $290.3K $146.9K $296.1K $0.00 $3.800M $1.300M $1.200M $500.0K $600.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $100.0K $100.0K $0.00 $0.00
YoY Change -98.52% -1.03% 75.89% 57.16% -47.87% 945.67% -48.6% 15603.85% -50.0% 128.57% -39.71% 97.63% -50.4% -100.0% 192.31% 8.33% 140.0% -16.67% 200.0% -100.0% 0.0% 0.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1993 1992 1991
Revenue $3.551M $240.7M $243.2M $138.3M $87.99M $168.8M $16.14M $31.41M $200.0K $400.0K $175.0K $290.3K $146.9K $296.1K $0.00 $3.800M $1.300M $1.200M $500.0K $600.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $100.0K $100.0K $0.00 $0.00
Cost Of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $100.0K $0.00 $0.00
Gross Profit Margin 100.0% 0.0% 0.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1993 1992 1991
Selling, General & Admin $107.9M $101.3M $130.1M $80.08M $51.70M $26.60M $19.10M $20.30M $27.10M $23.10M $19.40M $8.100M $14.10M $6.600M $5.100M $14.00M $23.80M $16.90M $10.10M $4.900M $1.800M $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $200.0K $2.100M $400.0K $100.0K
YoY Change 6.47% -22.13% 62.46% 54.89% 94.36% 39.27% -5.91% -25.09% 17.32% 19.07% 139.51% -42.55% 113.64% 29.41% -63.57% -41.18% 40.83% 67.33% 106.12% 172.22% 1700.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -50.0% 425.0% 300.0%
% of Gross Profit 100.0% 2100.0%
Research & Development $505.9M $353.2M $297.3M $199.0M $128.9M $81.05M $52.97M $50.90M $55.30M $47.27M $23.14M $8.706M $5.391M $3.278M $500.0K $8.900M $12.10M $21.00M $8.200M $2.900M $600.0K $0.00 $0.00 $200.0K $300.0K $100.0K
YoY Change 43.23% 18.8% 49.42% 54.4% 59.01% 53.01% 4.05% -7.95% 16.99% 104.28% 165.78% 61.47% 64.49% 555.55% -94.38% -26.45% -42.38% 156.1% 182.76% 383.33% -33.33% 200.0%
% of Gross Profit 200.0%
Depreciation & Amortization $16.90M $10.70M $8.700M $6.600M $4.200M $2.700M $2.999M $2.990M $1.546M $2.300M $1.346M $1.751M $1.749M $268.0K $300.0K $1.000M $1.100M $1.000M $900.0K $600.0K $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $200.0K $100.0K $0.00
YoY Change 57.94% 22.99% 31.82% 57.14% 55.56% -9.97% 0.3% 93.44% -32.79% 70.92% -23.17% 0.14% 552.66% -10.67% -70.0% -9.09% 10.0% 11.11% 50.0% 500.0% -100.0% 0.0% 100.0%
% of Gross Profit 0.0% 200.0%
Operating Expenses $604.6M $445.7M $421.7M $287.3M $181.2M $81.05M $52.97M $50.90M $79.80M $96.36M $53.45M $24.88M $21.24M $10.13M $5.800M $23.30M $36.30M $38.30M $18.70M $8.000M $2.400M $100.0K $200.0K $200.0K $100.0K $100.0K $100.0K $200.0K $300.0K $2.400M $800.0K $200.0K
YoY Change 35.65% 5.69% 46.78% 58.61% 123.51% 53.01% 4.05% -36.21% -17.18% 80.27% 114.84% 17.16% 109.71% 74.59% -75.11% -35.81% -5.22% 104.81% 133.75% 233.33% 2300.0% -50.0% 0.0% 100.0% 0.0% 0.0% -50.0% -33.33% 200.0% 300.0%
Operating Profit -$601.1M -$205.0M -$178.5M -$149.0M -$93.16M $61.19M -$53.28M -$24.59M -$21.09M -$9.830M -$200.0K -$200.0K -$100.0K -$100.0K $0.00 -$200.0K -$300.0K -$2.300M -$800.0K -$200.0K
YoY Change 193.21% 14.84% 19.77% 59.98% -252.24% 116.66% 16.6% 114.53% 0.0% 100.0% 0.0% -100.0% -33.33% 187.5% 300.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1993 1992 1991
Interest Expense -$9.632M $18.33M $5.033M $6.120M $9.191M $6.958M $1.049M $415.1K $0.00 $3.600M -$5.500M -$6.000M $100.0K $800.0K $1.500M $300.0K $600.0K $1.300M $1.200M $2.500M $0.00 $0.00 -$200.0K -$100.0K -$100.0K -$100.0K -$100.0K $0.00 $0.00
YoY Change -152.56% 264.12% -17.76% -33.41% 32.09% 563.58% 152.58% -100.0% -165.45% -8.33% -6100.0% -87.5% -46.67% 400.0% -50.0% -53.85% 8.33% -52.0% -100.0% 100.0% 0.0% 0.0% 0.0%
% of Operating Profit 11.37%
Other Income/Expense, Net -$11.38M -$1.489M $5.798M $2.070M $8.608M $6.958M $1.488M $2.618M $22.12K $400.0K -$5.444M -$7.114M -$1.021M $1.045M $0.00 $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$700.0K $0.00 $100.0K $0.00 $0.00
YoY Change 664.27% -125.68% 180.1% -75.95% 23.72% 367.54% -43.16% 11733.37% -94.47% -107.35% -23.48% 596.45% -197.72% -100.0% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1993 1992 1991
Pretax Income -$612.5M -$206.5M -$172.7M -$140.8M -$84.55M $68.15M -$54.45M -$34.38M -$81.72M -$91.90M -$58.72M -$31.70M -$22.11M -$8.785M -$4.300M -$19.10M -$34.40M -$35.80M -$17.10M -$4.900M -$2.200M -$100.0K -$200.0K -$200.0K -$100.0K -$400.0K -$200.0K -$900.0K -$300.0K -$2.300M -$700.0K -$200.0K
YoY Change 196.6% 19.56% 22.62% 66.58% -224.07% -225.16% 58.38% -57.93% -11.08% 56.51% 85.22% 43.38% 151.69% 104.3% -77.49% -44.48% -3.91% 109.36% 248.98% 122.73% 2100.0% -50.0% 0.0% 100.0% -75.0% 100.0% -77.78% 200.0% 228.57% 250.0%
Income Tax -$2.767M $2.784M $3.785M $2.000K $2.000K $173.6K $2.400K $2.400K $2.400K $2.400K $5.300K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.25%
Net Earnings -$599.5M -$205.3M -$176.1M -$140.8M -$84.55M $67.97M -$54.45M -$34.38M -$81.72M -$91.94M -$58.63M -$31.14M -$21.13M -$3.129M -$6.957M -$19.31M -$27.24M -$30.71M -$19.96M -$6.733M -$751.3K -$95.24K -$200.0K -$200.0K -$100.0K $600.0K -$200.0K -$900.0K -$300.0K -$2.300M -$700.0K -$200.0K
YoY Change 192.04% 16.59% 25.0% 66.58% -224.39% -224.84% 58.38% -57.93% -11.11% 56.81% 88.26% 47.42% 575.19% -55.03% -63.97% -29.12% -11.3% 53.86% 196.46% 796.29% 688.82% -52.38% 0.0% 100.0% -116.67% -400.0% -77.78% 200.0% 228.57% 250.0%
Net Earnings / Revenue -16882.37% -85.27% -72.39% -101.85% -96.09% 40.27% -337.32% -109.46% -40861.5% -22985.22% -33502.97% -10729.22% -14383.61% -1056.56% -508.12% -2095.51% -2559.41% -3992.39% -1122.24% -375.63% -200.0% -900.0% -300.0% -2300.0%
Basic Earnings Per Share -$5.00 -$1.92 -$1.67 -$1.36 -$0.84 $0.72 -$0.65 -$0.47 -$1.90 -$0.44
Diluted Earnings Per Share -$5.00 -$1.92 -$1.67 -$1.358M -$0.84 $0.69 -$0.65 -$0.47 -$1.337M -$1.601M -$1.249M -$1.296M -$1.901M -$430.6K -$906.2K -$4.289M -$6.949M -$8.306M -$5.938M -$3.632M -$2.273M -$13.19M -$30.32M -$23.22M -$17.74M -$61.42M -$33.82M -$177.2M -$59.01M -$1.469B -$1.145B -$381.2M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1993 1992 1991
Cash & Short-Term Investments $677.5M $395.7M $376.4M $367.8M $315.5M $258.7M $76.50M $65.60M $85.40M $98.80M $154.2M $28.10M $3.500M $8.100M $6.800M $2.000M $10.10M $24.10M $28.00M $22.50M $9.000M $1.400M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.700M $0.00 $0.00
YoY Change 71.21% 5.13% 2.34% 16.57% 21.96% 238.17% 16.62% -23.19% -13.56% -35.93% 448.75% 702.86% -56.79% 19.12% 240.0% -80.2% -58.09% -13.93% 24.44% 150.0% 542.86%
Cash & Equivalents $99.19M $103.0M $108.0M $184.4M $143.6M $221.8M $30.10M $24.80M $85.40M $81.20M $132.5M $19.10M $3.400M $7.500M $6.800M $2.000M $10.10M $24.10M $28.00M $22.50M $8.600M $1.400M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.700M $0.00 $0.00
Short-Term Investments $578.3M $292.7M $268.4M $183.4M $171.9M $36.90M $46.40M $40.80M $0.00 $17.50M $21.70M $9.000M $100.0K $600.0K $0.00 $0.00 $100.0K $500.0K $0.00
Other Short-Term Assets $18.01M $23.80M $27.49M $6.553M $6.100M $5.900M $1.900M $2.300M $5.100M $4.100M $600.0K $600.0K $600.0K $100.0K $300.0K $300.0K $400.0K $900.0K $700.0K $200.0K $400.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $0.00
YoY Change -24.33% -13.43% 319.55% 7.43% 3.39% 210.53% -17.39% -54.9% 24.39% 583.33% 0.0% 0.0% 500.0% -66.67% 0.0% -25.0% -55.56% 28.57% 250.0% -50.0% 100.0% 0.0%
Inventory $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $700.0K $600.0K $0.00 $0.00
Prepaid Expenses
Receivables $0.00 $1.410M $10.26M $800.0K $700.0K $300.0K $100.0K $100.0K $0.00 $100.0K $0.00 $0.00 $100.0K $100.0K $100.0K $300.0K $0.00 $0.00 $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.500M $1.600M $800.0K $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $695.5M $419.5M $405.3M $384.6M $322.4M $265.2M $78.80M $67.90M $90.50M $102.9M $154.8M $28.80M $6.600M $9.900M $8.100M $2.500M $10.60M $25.30M $28.80M $22.80M $9.500M $1.500M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $700.0K $3.400M $100.0K $0.00
YoY Change 65.79% 3.5% 5.38% 19.29% 21.57% 236.55% 16.05% -24.97% -12.05% -33.53% 437.5% 336.36% -33.33% 22.22% 224.0% -76.42% -58.1% -12.15% 26.32% 140.0% 533.33% -100.0% 3300.0%
Property, Plant & Equipment $431.3M $335.6M $168.6M $66.02M $47.00M $23.20M $13.90M $15.50M $15.40M $4.500M $3.900M $3.500M $4.900M $0.00 $100.0K $500.0K $1.200M $500.0K $1.300M $1.100M $900.0K $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $100.0K $100.0K $500.0K $100.0K $100.0K
YoY Change 28.51% 99.07% 155.36% 40.47% 102.59% 66.91% -10.32% 0.65% 242.22% 15.38% 11.43% -28.57% -100.0% -80.0% -58.33% 140.0% -61.54% 18.18% 22.22% -100.0% 0.0% 0.0% 0.0% 400.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $105.9M $245.6M $137.5M $44.20M $0.00 $23.10M $1.700M $300.0K $2.000M $2.000M $2.200M $2.400M $0.00
YoY Change -100.0% -56.89% 78.61% 211.09% -100.0% 1258.82% 466.67% -85.0% 0.0% -9.09% -8.33%
Other Assets $4.482M $200.0K $218.0K $272.0K $300.0K $100.0K $100.0K $100.0K $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $300.0K $1.100M $200.0K $100.0K $100.0K $0.00
YoY Change 2141.0% -8.26% -19.85% -9.33% 200.0% 0.0% 0.0% 0.0% -100.0% -66.67% -72.73% 450.0% 100.0% 0.0%
Total Long-Term Assets $444.3M $346.1M $286.6M $325.6M $200.1M $84.60M $32.80M $36.10M $37.70M $29.40M $28.00M $8.500M $9.900M $6.000M $4.300M $5.200M $6.700M $4.600M $5.700M $6.200M $2.400M $0.00 $100.0K $0.00 $100.0K $100.0K $100.0K $100.0K $200.0K $800.0K $400.0K $200.0K
YoY Change 28.38% 20.74% -11.95% 62.69% 136.52% 157.93% -9.14% -4.24% 28.23% 5.0% 229.41% -14.14% 65.0% 39.53% -17.31% -22.39% 45.65% -19.3% -8.06% 158.33% -100.0% -100.0% 0.0% 0.0% 0.0% -50.0% 100.0% 100.0%
Total Assets $1.140B $765.6M $691.9M $710.1M $522.5M $349.8M $111.6M $104.0M $128.2M $132.3M $182.8M $37.30M $16.50M $15.90M $12.40M $7.700M $17.30M $29.90M $34.50M $29.00M $11.90M $1.500M $100.0K $0.00 $100.0K $100.0K $100.0K $100.0K $900.0K $4.200M $500.0K $200.0K
YoY Change
Accounts Payable $11.39M $35.90M $2.868M $9.457M $6.800M $7.600M $2.800M $4.100M $12.20M $5.000M $2.600M $1.200M $900.0K $600.0K $700.0K $1.000M $1.300M $1.300M $800.0K $500.0K $500.0K $100.0K $300.0K $200.0K $200.0K $200.0K $1.400M $1.100M $1.100M $600.0K $200.0K $0.00
YoY Change -68.28% 1151.74% -69.67% 39.07% -10.53% 171.43% -31.71% -66.39% 144.0% 92.31% 116.67% 33.33% 50.0% -14.29% -30.0% -23.08% 0.0% 62.5% 60.0% 0.0% 400.0% -66.67% 50.0% 0.0% 0.0% -85.71% 27.27% 0.0% 200.0%
Accrued Expenses $91.35M $68.30M $61.88M $26.02M $14.50M $11.50M $9.000M $8.000M $8.600M $9.200M $4.700M $1.500M $1.900M $1.100M $700.0K $600.0K $1.600M $1.400M $900.0K $400.0K $100.0K $0.00 $700.0K $600.0K $500.0K $300.0K $400.0K $200.0K $200.0K $100.0K $0.00 $0.00
YoY Change 33.75% 10.37% 137.79% 79.48% 26.09% 27.78% 12.5% -6.98% -6.52% 95.74% 213.33% -21.05% 72.73% 57.14% 16.67% -62.5% 14.29% 55.56% 125.0% 300.0% -100.0% 16.67% 20.0% 66.67% -25.0% 100.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $500.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $600.0K $500.0K $500.0K $500.0K $500.0K $800.0K $800.0K $200.0K $0.00 $0.00
YoY Change -100.0% -100.0% 20.0% 0.0% 0.0% 0.0% -37.5% 0.0%
Long-Term Debt Due $0.00 $200.0K $200.0K $200.0K $200.0K $300.0K $1.200M $300.0K $700.0K $800.0K $0.00 $1.200M $0.00 $0.00 $0.00 $0.00 $0.00 $500.0K $300.0K $300.0K $0.00 $0.00 $0.00
YoY Change -100.0% 0.0% 0.0% 0.0% -33.33% -75.0% 300.0% -12.5% -100.0% -100.0% 66.67% 0.0%
Total Short-Term Liabilities $103.2M $105.5M $138.9M $146.5M $40.70M $97.10M $12.40M $18.70M $25.60M $15.90M $11.80M $8.700M $5.300M $2.600M $4.300M $2.300M $3.700M $2.900M $2.900M $1.000M $700.0K $100.0K $1.600M $1.300M $1.200M $1.000M $2.800M $2.700M $2.600M $1.000M $300.0K $0.00
YoY Change -2.21% -24.02% -5.25% 260.04% -58.08% 683.06% -33.69% -26.95% 61.01% 34.75% 35.63% 64.15% 103.85% -39.53% 86.96% -37.84% 27.59% 0.0% 190.0% 42.86% 600.0% -93.75% 23.08% 8.33% 20.0% -64.29% 3.7% 3.85% 233.33%
Long-Term Debt $393.2M $0.00 $0.00 $0.00 $0.00 $0.00 $2.100M $2.300M $2.500M $500.0K $800.0K $1.100M $2.100M $600.0K $0.00 $500.0K $700.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $400.0K $100.0K $100.0K
YoY Change -100.0% -8.7% -8.0% 400.0% -37.5% -27.27% -47.62% 250.0% -100.0% -28.57% 300.0% 0.0%
Other Long-Term Liabilities $452.4M $372.9M $134.8M $154.8M $20.00M $8.700M $1.900M $2.100M $5.000M $6.200M $4.200M $1.800M $300.0K $100.0K $0.00 $0.00 $500.0K $500.0K $0.00
YoY Change 21.32% 176.73% -12.95% 673.95% 129.89% 357.89% -9.52% -58.0% -19.35% 47.62% 133.33% 500.0% 200.0% -100.0% 0.0%
Total Long-Term Liabilities $845.6M $372.9M $134.8M $154.8M $20.00M $8.700M $4.000M $4.400M $7.500M $6.700M $5.000M $2.900M $2.400M $700.0K $0.00 $500.0K $1.200M $500.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $400.0K $100.0K $100.0K
YoY Change 126.76% 176.73% -12.95% 673.95% 129.89% 117.5% -9.09% -41.33% 11.94% 34.0% 72.41% 20.83% 242.86% -100.0% -58.33% 140.0% 300.0% 0.0%
Total Liabilities $954.4M $494.2M $293.4M $301.3M $60.70M $105.3M $15.80M $22.60M $32.60M $22.10M $16.30M $9.800M $6.500M $3.100M $3.300M $2.800M $5.000M $3.600M $3.900M $2.900M $2.500M $100.0K $1.600M $1.400M $1.200M $1.100M $2.900M $2.700M $2.600M $1.400M $400.0K $200.0K
YoY Change 93.11% 68.43% -2.62% 396.42% -42.36% 566.46% -30.09% -30.67% 47.51% 35.58% 66.33% 50.77% 109.68% -6.06% 17.86% -44.0% 38.89% -7.69% 34.48% 16.0% 2400.0% -93.75% 14.29% 16.67% 9.09% -62.07% 7.41% 3.85% 250.0% 100.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1993 1992 1991
Basic Shares Outstanding 119.8M shares 106.8M shares 105.4M shares 103.7M shares 100.7M 93.86M 83.64M 73.90M 11.13M shares 7.181M shares
Diluted Shares Outstanding 119.8M shares 106.8M shares 105.4M shares 103.7M 100.7M 98.61M 83.64M 73.90M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.8757 Billion

About ARROWHEAD PHARMACEUTICALS, INC.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The company is headquartered in Pasadena, California and currently employs 525 full-time employees. The firm's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The firm's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The company is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. The company has around 14 clinical-stage investigational medicines (nine wholly owned and five partnered), which range in development stage from Phase I to Phase III. The firm's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MUC5AC, ARO-MMP7, GSK-4532990, Fazirsiran, JNJ-3989, HZN-457, ARO-C3, ARO-PNPLA3, ARO-DUX4 and ARO-SOD1.

Industry: Pharmaceutical Preparations Peers: ACADIA PHARMACEUTICALS INC AMICUS THERAPEUTICS, INC. Beam Therapeutics Inc. ChemoCentryx, Inc. Denali Therapeutics Inc. INSMED Inc Mirati Therapeutics, Inc. PTC THERAPEUTICS, INC. Ultragenyx Pharmaceutical Inc.